LGD1069
Jump to navigation
Jump to search
LGD1069 | |
---|---|
Term | LGD1069 |
Short definition | LGD1069 - A drug used to treat skin problems caused by cutaneous T-cell lymphoma that did not improve after another treatment. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
LGD1069 - A drug used to treat skin problems caused by cutaneous T-cell lymphoma that did not improve after another treatment. It is also being studied in the treatment of other types of cancer. LGD1069 binds to and activates proteins called retinoid X receptors, which can stop cancer cells from growing and kill them. It's a type of retinoid. Also called bexarotene and targretin
External links
- Medical encyclopedia article on LGD1069
- Wikipedia's article - LGD1069
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski